LOGIN 

 

JOIN

 

RENEW

Journal Club

HomeMembersAssemblies and SectionsAssembliesAllergy, Immunology and InflammationJournal Club ▶ SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness

Webinar date:  August 20, 2020, at 1:30 PM EDT

This webinar was sponsored by the Assembly on Allergy, Immunology & Inflammation (AII), and featured the article: "SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness".

Presenter:
Kizzmekia Corbett, PhD, Scientific Lead of the Vaccine Research Center Coronavirus Team, National Institute of Allergy and Infectious Diseases, NIH


Moderator:
Catherine Bonham, MD, Assistant Professor of Medicine, Division of Pulmonary and Critical Care Medicine, University of Virginia